Literature DB >> 21074311

Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women.

Nikolaos Vitoratos1, Irene Lambrinoudaki, Demetrios Rizos, Eleni Armeni, Andreas Alexandrou, George Creatsas.   

Abstract

OBJECTIVE: To evaluate alterations in the concentrations of osteoprotegerin (OPG), RANKL and the OPG/RANKL ratio in pre-eclamptic women during the puerperium. STUDY
DESIGN: This cross-sectional study was performed in the maternity ward of Aretaieio Hospital in Athens, Greece. Fifteen pregnant women with severe pre-eclampsia and 15 matched controls with premature rupture of the membranes were recruited. Fasting blood samples were obtained antepartum, immediately after diagnosing pre-eclampsia (median: 32nd gestational week), and during the 3rd-6th day postpartum, to estimate levels of circulating OPG and RANKL as well as the OPG/RANKL ratio. The anthropometric parameters evaluated included body mass index and blood pressure.
RESULTS: Mean circulating OPG levels decreased significantly in both groups in the postpartum period (controls: 43.7 ± 19.1 ng/ml vs 22.9 ± 9.1 ng/ml, p = 0.008; pre-eclamptic group: 72.3 ± 49.9 vs 49.7 ± 40.9 ng/ml, p = 0.002). The antepartum OPG/RANKL ratio was elevated in hypertensive pregnancies (2.41 ± 1.72) compared to normotensive pregnancies (1.45 ± 0.63), but the difference did not reach statistical significance (p = 0.1). The OPG/RANKL ratio decreased in the control group (0.76 ± 0.30, NS) following delivery, while it remained unchanged in the pre-eclamptic women (1.63 ± 1.40, p = 0.13). Consequently, the postpartum OPG/RANKL ratio was significantly higher in the pre-eclamptic women compared to control women (1.63 ± 1.40 vs 0.76 ± 0.30, p = 0.01). Levels of RANKL demonstrated no significant alterations during puerperium in both cases.
CONCLUSION: Pregnancies complicated with pre-eclampsia exhibit higher OPG levels and OPG/RANKL ratios, compared to control pregnancies, which might be compatible with lower bone turnover. The significance of this finding with respect to bone metabolism remains to be elucidated in larger studies.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074311     DOI: 10.1016/j.ejogrb.2010.10.009

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.

Authors:  Rafał Rzepka; Barbara Dołęgowska; Daria Sałata; Aleksandra Rajewska; Marta Budkowska; Leszek Domański; Sebastian Kwiatkowski; Wioletta Mikołajek-Bedner; Andrzej Torbé
Journal:  BMC Pregnancy Childbirth       Date:  2015-06-10       Impact factor: 3.007

2.  Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups.

Authors:  Benjamin Navet; Jorge William Vargas-Franco; Andrea Gama; Jérome Amiaud; Yongwon Choi; Hideo Yagita; Christopher G Mueller; Françoise Rédini; Dominique Heymann; Beatriz Castaneda; Frédéric Lézot
Journal:  J Clin Med       Date:  2018-11-08       Impact factor: 4.241

3.  Identification and validation of key non-coding RNAs and mRNAs using co-expression network analysis in pre-eclampsia.

Authors:  Jing He; Kang Liu; Xiaohong Hou; Jieqiang Lu
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

4.  Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.

Authors:  Alessandro Rolfo; Domenica Giuffrida; Anna Maria Nuzzo; Daniele Pierobon; Simona Cardaropoli; Ettore Piccoli; Mirella Giovarelli; Tullia Todros
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

5.  Circulating Levels of Bone and Inflammatory Markers in Gestational Diabetes Mellitus.

Authors:  Deirdre Cocks Eschler; Georgia Kulina; Adolfo Garcia-Ocana; Jiawen Li; Thomas Kraus; Carol J Levy
Journal:  Biores Open Access       Date:  2018-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.